🔗 Share this article

Treasury head Reeves has stated she is preparing "specific action to tackle cost of living pressures" in the forthcoming Budget.

Speaking to the BBC, she stated that curbing price rises is a collective duty of both the government and the central bank.

The United Kingdom's inflation rate is forecast to be the highest among the Group of Seven advanced economies this calendar year and next.

Possible Energy Cost Interventions

Sources suggest the administration could take action to lower utility costs, for instance by cutting the present 5% level of value-added tax charged on energy supplies.

An additional option is to cut some of the policy costs currently included in bills.

Budgetary Constraints and Expert Predictions

The government will obtain the next draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will clarify how much scope there is for these measures.

The consensus from the majority of analysts is that Reeves will have to announce tax increases or expenditure reductions in order to fulfill her voluntary borrowing rules.

Previously on the same day, calculations indicated there was a £22 billion deficit for the Treasury chief to address, which is at the more modest range of projections.

"It is a shared task between the central bank and the government to continue tackling some of the drivers of inflation," Reeves stated to reporters in the US capital, at the conferences of the International Monetary Fund and World Bank.

Tax Pledges and International Issues

While a great deal of the attention has been on expected tax rises, the Treasury chief said the latest data from the fiscal watchdog had not altered her pledge to campaign commitments not to increase rates on earnings tax, VAT or social security contributions.

She attributed an "unpredictable world" with rising geopolitical and trade tensions for the Budget tax moves, likely to be targeted on those "with the broadest shoulders."

Global Economic Disputes

Commenting on apprehensions about the United Kingdom's economic relations with China she said: "The UK's security interests always take priority."

Recent statement by China to strengthen trade restrictions on rare earths and other materials that are crucial for high-technology manufacturing led American leader the US President to threaten an extra 100% import tax on goods from the Asian country, increasing the prospect of an all-out trade war between the two largest economies.

The US Treasury Secretary called the Chinese move "economic coercion" and "a international production power grab."

Inquired about accepting the US offer to join its dispute with China, Reeves said she was "deeply worried" by Chinese actions and urged the Chinese government "not to put up barriers and restrict access."

She said the move was "bad for the world economy and creates additional headwinds."

"In my view there are fields where we need to address China, but there are also significant opportunities to sell into Chinese markets, including financial services and other areas of the economic system. We've got to get that equilibrium correct."

The Treasury chief also affirmed she was collaborating with other major economies "on our own essential resources approach, so that we are more independent."

Health Service Medicine Costs and Investment

The Chancellor also recognized that the cost the NHS spends on drugs could go up as a consequence of current discussions with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and capital.

Some of the biggest global drug companies have said recently that they are either pausing or abandoning investments in the United Kingdom, with some blaming the insufficient payments they are receiving.

Last month, the government science advisor said the cost the health service pays for drugs would need to rise to halt businesses and pharmaceutical investment departing from the United Kingdom.

Reeves informed the BBC: "It has been observed because of the pricing regime, that clinical trials, innovative medicines have not been offered in the UK in the way that they are in other EU nations."

"The objective is to make sure that people receiving care from the NHS are able to receive the finest life-saving treatments in the world. And so we are reviewing all of that, and... seeking to secure increased investment into Britain."